Search for: "Watson v. US"
Results 361 - 380
of 919
Sorted by Relevance
|
Sort by Date
1 Jun 2009, 12:44 pm
US ex rel. [read post]
7 Nov 2007, 6:44 am
MacDonald Watson Waste Oil Co., 933 F.2d 35 (1st Cir. 1991) and United States v. [read post]
3 Apr 2017, 3:00 am
In Beck v. [read post]
30 Jul 2007, 8:18 am
Tuesday, Oct. 9 Watson v. [read post]
16 Aug 2024, 3:00 am
All seven state ballot measures considered following the Supreme Court’s 2022 Dobbs v. [read post]
3 Jun 2007, 7:11 pm
Watson, 423 U.S. 411, 424 (1976) (finding consent to search voluntarily offered despite formal arrest); see also United States v. [read post]
15 Feb 2011, 5:26 pm
: Ineos Healthcare v OHMI – Teva (Class 46) Androderm (Testosterone) – US: Watson settles with Promote Innovation in Androderm false marking suit (Patent Docs) Asacol (Mesalamine) – US: Roxane sanctioned in Asacol patent dispute with Medeva (Patent Docs) Detrol (Tolterodine) – US: Subsequent ANDA sponsor says Detrol LA patent has gotta go; But would a final court decision trigger 180-day exclusivity? [read post]
29 Jun 2011, 10:25 pm
United States v. [read post]
6 May 2015, 5:03 am
Watson, 423 U.S. 411, 416, 96 S. [read post]
6 Apr 2011, 12:18 am
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) –… [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson… [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) - Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) - US: Watson and Barr settle patent… [read post]
4 Nov 2009, 4:03 am
Stakeholders react to draft report (IP Watch) US: District Court S D New York denies motions to dismiss in gene patent case: Association for Molecular Pathology v USPTO (Inventive Step) (Patent Docs) (Patent Baristas) (Ars Technica) (The IP Factor) (Patently-O) (IP Watch) Products Ceclor (Cefaclor) – Canada: Eli Lilly successful in patent infringement action against Apotex (Pharmacapsules @ Gowlings) Oxytrol (Oxybutynin) – US: Watson and Barr… [read post]
3 Jun 2010, 5:35 am
– In re Ciprofloxacin Antitrust Litigation (PatLit) Circumvent PCV and Porcilis PCV vaccines – US: Wyeth files patent infringement suit against Intervet based on their manufacture of PCV vaccines (Patent Docs) Copegus (Ribavirin) – US: Ascio seeks declaratory judgment of unenforceability, invalidity and non-infringement of Three Rivers’ patent based on ANDA filing (Patent Docs) Entocort (Budesonide) – US: AstraZeneca settles Entocort patent… [read post]
17 Nov 2018, 12:10 pm
At times the authors rail at the use of statistical significance as the “sole” criterion, and at times, they seem to criticize its use at all. [read post]
20 Sep 2010, 11:17 pm
S.C. ruling in Danicek v. [read post]
3 Mar 2009, 4:01 am
" The Circuit Court said that "neither the ADA nor the Rehabilitation Act requires employers to forgo a qualification standard "until a perceived threat becomes real or questionable behavior results in injuries," citing Watson v. [read post]
13 Oct 2015, 9:10 am
Problem for US patent system: difficult to reform patent law b/c you have two statutes and two venues. eBay v. [read post]
4 Jun 2015, 7:25 am
Watson: business as usual in claim construction after TevaGevo v. [read post]
17 Jun 2009, 3:02 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Gene patenting debate continues: UCLA v USPTO (Patent Docs) (Patent Docs) (PatentlyBIOtech) (Patent Docs) (IP Watchdog) US: FTC issues highly anticipated report on follow-on biologics; report concludes that special legislative exclusivity incentives are largely unwarranted for innovators and generics (FDA Law Blog) (Patent… [read post]
